TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,053,125 | -34.8% | 37,500 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $3,149,250 | +31.2% | 37,500 | +18.3% | 0.00% | 0.0% |
Q1 2023 | $2,400,641 | +22.7% | 31,700 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,956,524 | +123.1% | 31,700 | +51.0% | 0.00% | – |
Q3 2022 | $877,000 | +32.9% | 21,000 | 0.0% | 0.00% | – |
Q2 2022 | $660,000 | +16.6% | 21,000 | 0.0% | 0.00% | – |
Q1 2022 | $566,000 | +40.8% | 21,000 | 0.0% | 0.00% | – |
Q4 2021 | $402,000 | -47.4% | 21,000 | -9.1% | 0.00% | – |
Q3 2021 | $764,000 | -0.3% | 23,100 | 0.0% | 0.00% | – |
Q2 2021 | $766,000 | -20.0% | 23,100 | 0.0% | 0.00% | – |
Q1 2021 | $958,000 | +95.5% | 23,100 | -6.1% | 0.00% | – |
Q4 2020 | $490,000 | +44.5% | 24,600 | 0.0% | 0.00% | – |
Q3 2020 | $339,000 | -23.1% | 24,600 | 0.0% | 0.00% | – |
Q2 2020 | $441,000 | +94.3% | 24,600 | +30.9% | 0.00% | – |
Q1 2020 | $227,000 | +0.4% | 18,800 | +58.0% | 0.00% | – |
Q4 2019 | $226,000 | -15.0% | 11,900 | +6.2% | 0.00% | – |
Q3 2019 | $266,000 | – | 11,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roubaix Capital, LLC | 264,438 | $5,027,000 | 4.84% |
Abrams Capital Management | 3,499,859 | $66,532,000 | 2.07% |
Sandhill Capital Partners LLC | 736,175 | $13,995,000 | 1.55% |
EMERALD ADVISERS, LLC | 451,542 | $8,584,000 | 0.36% |
RTW INVESTMENTS, LP | 503,266 | $9,567,000 | 0.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 429,868 | $8,172,000 | 0.33% |
NEXT CENTURY GROWTH INVESTORS LLC | 107,045 | $2,034,000 | 0.26% |
ELEMENT CAPITAL MANAGEMENT LLC | 63,175 | $1,201,000 | 0.26% |
HAMILTON LANE ADVISORS LLC | 19,364 | $368,000 | 0.16% |
Harbour Capital Advisors, LLC | 20,900 | $397,000 | 0.15% |